Lucky Core Industries Limited · PSX:LCI
Lucky Core Industries — H1 FY2024-25 Earnings Presentation
14 slides from Lucky Core Industries's earnings presentation, March 2025
Slide 1: Corporate Briefing Session
Corporate Briefing Session Six Months Ended Dec’ 24
Slide 2: H1 FY 24-25 – At a Glance
H1 FY 24-25 – At a Glance Unconsolidated Consolidated Financials Financials Revenue 3% Revenue 4% PKR 62,272 Mln PKR 62,246 Mln EBIT 16% EBIT 16% PKR 9,340 Mln PKR 9,400 Mln PAT 23% PAT 25% PKR 6,218 Mln PKR 6,301 Mln EPS 23% EPS 25% PKR 67.33 PKR 68.23
Slide 3: Key Highlights – H1 FY 2024-25
Key Highlights – H1 FY 2024-25 Avg Policy Rate Avg PKR Depreciation LSM (YTD Dec’24) Avg Inflation 17.6% 0.01% 0.02% 7.22% Integration of Pfizer portfolio and better margins in The Company completed an asset acquisition from 1 Pfizer Pakistan Ltd. and other Pfizer entities. 2 Polyester and Pharmaceu
Slide 4: Strong Capital Structure
Strong Capital Structure Healthy payout and low gearing ratios, whilst investing heavily in growth/expansion projects. PKR’ m Ratios FY'20 FY'21 FY'22 FY'23 FY'24 H1 FY'25 ROCE 20% 29% 35% 45% 48% 47%** Healthy PAT 3,096 5,959 6,249 13,772* 11,140 6,218 Returns Payout Ratio 47% 62% 52% 50% 50% 50% *
Slide 5: Historical Performance post YBG Acquisition
Historical Performance post YBG Acquisition YoY Growth 13,772 23% 11,140 7,889 5,959 6,249 6,218 5,040 2,843 3,296 3,060 3,096 1,702 2,126 2,305 FY'14 FY'15 FY'16 FY'17 FY'18 FY'19 FY'20 FY'21 FY'22 FY'23 FY'24 H1 FY'24 H1 FY'25 PAT Inc. NutriCo Gain PAT Exc. NutriCo Gain *PAT CAGR calculated from 2
Slide 6: Company Performance H1 FY 24-25
Company Performance H1 FY 24-25
Slide 7: Financial Performance by Business – Standalone
Financial Performance by Business – Standalone Resilient performance despite challenging economic conditions. Chemicals & Agri Soda Ash Polyester Pharmaceuticals Animal Health LCI Sciences 20,221 17% 22,169 13% 10,429 80% 6,616 6% 2,789 14% 62,272 3% NSI Vs. 24,505 Vs. 19,692 Vs. 5,782 Vs. 7,007 Vs.
Slide 8: Soda Ash
Financial Performance – Soda Ash Weak demand impacted domestic sales and declining commodity prices impacted exports. Amount in PKR Bln 47.56 10.03 41.42 Revenue 7.63 25.06 24.50 EBIT 20.22 4.48 4.82 16.54 16.71 4.27 15.65 3.63 3.28 3.53 FY19 FY20 FY21 FY22 FY23 FY24 H1 H1 FY19 FY20 FY21 FY22 FY23 F
Slide 9: Polyester
Financial Performance – Polyester Increased volumes and higher global freight rates resulted in better margins. Amount in PKR Bln 40.45 40.28 36.68 3.81 Revenue 23.63 24.30 3.19 22.17 EBIT 19.89 19.69 2.72 1.83 1.24 0.71 0.65 0.07 FY19 FY20 FY21 FY22 FY23 FY24 H1 H1 FY19 FY20 FY21 FY22 FY23 FY24 H1
Slide 10: Pharmaceuticals
Financial Performance – Pharmaceuticals Integration of Pfizer portfolio, stability of PKR and certain price adjustments resulted in improvement. Amount in PKR Bln Revenue EBIT EBITDA
Slide 11: Asset Acquisition from Pfizer Entities
Asset Acquisition from Pfizer Entities Completed on 6th September, 2024 Acquisition of a manufacturing facility and the following brands Ansaid Ponstan Lysovit Deltacortril Mycitracin Corex-D Basoquin
Slide 12: Animal Health
Financial Performance – Animal Health Decline in livestock and poultry market, reduced purchasing power and imposition of sales tax on feed impacted the business. Amount in PKR Bln 6.84 6.78 5.62 5.11 Revenue 0.93 0.88 3.91 EBIT 3.73 0.76 3.33 2.88 0.50 0.48 0.38 0.26 0.24 FY19 FY20 FY21 FY22 FY23 F
Slide 13: Chemicals & Agri Sciences
Financial Performance – Chemicals & Agri Sciences Reduced margins impacted the chemicals and masterbatches segment. Liquidity constraints and adverse weather conditions impacted the Agri segment. Amount in PKR Bln 13.70 2.11 11.71 1.89 10.81 Revenue 1.46 8.70 EBIT 8.11 8.02 7.01 1.14 6.62 0.96 0.94
Slide 14: Q&A Session
Q&A Session
Lucky Core Industries — H1 FY2024-25 Earnings Presentation on 6ix